• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫酸乙酰肝素蛋白聚糖-1 及外源性肝素在肝癌球形成中的作用。

Role of syndecan-1 and exogenous heparin in hepatoma sphere formation.

机构信息

Far Eastern Memorial Hospital, Banqiao District, New Taipei City, Taiwan, 22060.

School of Medicine, Fu Jen Catholic University, Xinzhuang District, New Taipei City, Taiwan, 24205.

出版信息

Biochem Cell Biol. 2020 Apr;98(2):112-119. doi: 10.1139/bcb-2018-0246. Epub 2019 May 1.

DOI:10.1139/bcb-2018-0246
PMID:31042409
Abstract

Glycosaminoglycan-modified proteoglycans play important roles in many cell activities, including cell differentiation and stem cell development. Tumor sphere formation ability is one of properties in cancer stem cells (CSCs). The correlation between CSC markers and proteoglycan remains to be clarified. Upon hepatoma sphere formation, expression of CSC markers CD13, CD90, CD133, and CD44, as well the syndecan family protein syndecan-1 (SDC1), increased as analyzed by PCR. Further examination by suppression of CD13 expression showed downregulation of SDC1 and CD44 gene expression, whereas suppression of SDC1 gene expression downregulated CD13 and CD44 gene expression. Suppression of SDC1 gene expression also suppressed sphere development, as analyzed by a novel sphereocrit assay to quantify the level of sphere formation. The heparin disaccharide components, but not those of chondroitin disaccharide, changed with hepatoma sphere development, revealing the increased levels of -sulfation and 2-O-sulfation. These explained the inhibition of hepatoma sphere formation by exogenous heparin. In conclusion, we found that SDC1 affected CSC marker CD13 and CD44 expression. SDC1 proteoglycan and heparin components changed and affected hepatoma sphere development. Application of heparin mimics in reduction of hepatoma stem cells might be possible.

摘要

糖胺聚糖修饰的蛋白聚糖在许多细胞活动中发挥重要作用,包括细胞分化和干细胞发育。肿瘤球形成能力是癌症干细胞(CSC)的特性之一。CSC 标志物与蛋白聚糖之间的相关性仍需阐明。通过肝癌球体形成分析发现,CSC 标志物 CD13、CD90、CD133 和 CD44 的表达增加,通过 PCR 分析发现 syndecan 家族蛋白 syndecan-1(SDC1)的表达增加。进一步通过抑制 CD13 的表达进行检查显示,SDC1 和 CD44 基因表达下调,而 SDC1 基因表达的抑制下调 CD13 和 CD44 基因表达。通过新型球体测定法分析球体发育,发现 SDC1 基因表达的抑制也抑制了球体的形成,该方法可定量测定球体形成的水平。肝素二糖成分而不是软骨素二糖成分随肝癌球体的发育而变化,揭示了 -硫酸化和 2-O-硫酸化水平的增加。这解释了外源性肝素抑制肝癌球体形成的原因。总之,我们发现 SDC1 影响 CSC 标志物 CD13 和 CD44 的表达。SDC1 蛋白聚糖和肝素成分发生变化并影响肝癌球体的发育。肝素类似物在减少肝癌干细胞方面的应用可能是可行的。

相似文献

1
Role of syndecan-1 and exogenous heparin in hepatoma sphere formation.硫酸乙酰肝素蛋白聚糖-1 及外源性肝素在肝癌球形成中的作用。
Biochem Cell Biol. 2020 Apr;98(2):112-119. doi: 10.1139/bcb-2018-0246. Epub 2019 May 1.
2
Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.肝癌细胞系中具有癌症干细胞特性的球体形成细胞亚群。
BMC Gastroenterol. 2011 Jun 14;11:71. doi: 10.1186/1471-230X-11-71.
3
NEAT1 is Required for the Expression of the Liver Cancer Stem Cell Marker CD44.NEAT1 对于肝癌干细胞标志物 CD44 的表达是必需的。
Int J Mol Sci. 2020 Mar 11;21(6):1927. doi: 10.3390/ijms21061927.
4
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.Syndecan-1是三阴性炎性乳腺癌的一种新型分子标志物,并通过IL-6/STAT3、Notch和EGFR信号通路调节癌症干细胞表型。
Mol Cancer. 2017 Mar 7;16(1):57. doi: 10.1186/s12943-017-0621-z.
5
CD133-induced TM4SF5 expression promotes sphere growth via recruitment and blocking of protein tyrosine phosphatase receptor type F (PTPRF).CD133 诱导 TM4SF5 表达通过招募和阻断蛋白酪氨酸磷酸酶受体 F(PTPRF)促进球体生长。
Cancer Lett. 2018 Dec 1;438:219-231. doi: 10.1016/j.canlet.2018.09.009. Epub 2018 Sep 11.
6
A robust culture method for maintaining tumorigenic cancer stem cells in the hepatocellular carcinoma cell line Li-7.一种维持肝癌细胞系 Li-7 中的肿瘤发生癌症干细胞的健壮培养方法。
Cancer Sci. 2019 May;110(5):1644-1652. doi: 10.1111/cas.13978. Epub 2019 Mar 12.
7
The miR-200b-ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma.miR-200b-ZEB1 信号通路调控人肝细胞癌的多种干性。
Mol Carcinog. 2017 Sep;56(9):2035-2047. doi: 10.1002/mc.22657. Epub 2017 Apr 18.
8
Prognostic relevance of miR-137 in patients with hepatocellular carcinoma.miR-137 在肝细胞癌患者中的预后相关性。
Liver Int. 2017 Feb;37(2):271-279. doi: 10.1111/liv.13213. Epub 2016 Aug 16.
9
miR-589-5p inhibits MAP3K8 and suppresses CD90 cancer stem cells in hepatocellular carcinoma.微小RNA-589-5p抑制丝裂原活化蛋白激酶激酶激酶8并抑制肝细胞癌中的CD90癌干细胞。
J Exp Clin Cancer Res. 2016 Nov 11;35(1):176. doi: 10.1186/s13046-016-0452-6.
10
Metastatic ability and the epithelial-mesenchymal transition in induced cancer stem-like hepatoma cells.诱导的癌干细胞样肝癌细胞中的转移能力与上皮-间质转化
Cancer Sci. 2018 Apr;109(4):1101-1109. doi: 10.1111/cas.13527. Epub 2018 Mar 6.

引用本文的文献

1
Revealing a novel Decorin-expressing tumor stromal subset in hepatocellular carcinoma via integrative analysis single-cell RNA sequencing.通过整合分析单细胞RNA测序揭示肝细胞癌中一种表达核心蛋白聚糖的新型肿瘤基质亚群。
Cancer Cell Int. 2025 May 26;25(1):194. doi: 10.1186/s12935-025-03811-0.
2
Multifaceted role of heparin in oncology: from anticoagulation to anticancer mechanisms and clinical implications.肝素在肿瘤学中的多方面作用:从抗凝到抗癌机制及临床意义
Discov Oncol. 2025 Feb 24;16(1):231. doi: 10.1007/s12672-025-01985-7.
3
Biomedical applications of engineered heparin-based materials.
工程化肝素基材料的生物医学应用。
Bioact Mater. 2023 Aug 10;31:87-118. doi: 10.1016/j.bioactmat.2023.08.002. eCollection 2024 Jan.
4
Proteoglycans Determine the Dynamic Landscape of EMT and Cancer Cell Stemness.蛋白聚糖决定上皮-间质转化和癌细胞干性的动态格局。
Cancers (Basel). 2022 Oct 29;14(21):5328. doi: 10.3390/cancers14215328.
5
Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular Carcinoma.癌症中的蛋白聚糖:朋友还是敌人?特别关注肝细胞癌
Cancers (Basel). 2022 Apr 9;14(8):1902. doi: 10.3390/cancers14081902.
6
Drug-selected population in melanoma A2058 cells as melanoma stem-like cells retained angiogenic features - the potential roles of heparan-sulfate binding ANGPTL4 protein.在黑色素瘤 A2058 细胞中药物选择的人群作为黑色素瘤干细胞样细胞保留了血管生成特征-硫酸乙酰肝素结合 ANGPTL4 蛋白的潜在作用。
Aging (Albany NY). 2020 Nov 10;12(22):22700-22718. doi: 10.18632/aging.103890.
7
The anti-cancer properties of heparin and its derivatives: a review and prospect.肝素及其衍生物的抗癌特性:综述与展望。
Cell Adh Migr. 2020 Dec;14(1):118-128. doi: 10.1080/19336918.2020.1767489.